Inceptionr LLC Purchases 1,402 Shares of Tenet Healthcare Co. (NYSE:THC)

Inceptionr LLC boosted its position in shares of Tenet Healthcare Co. (NYSE:THC) by 25.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,870 shares of the company’s stock after purchasing an additional 1,402 shares during the period. Inceptionr LLC’s holdings in Tenet Healthcare were worth $867,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Raymond James Financial Inc. bought a new position in shares of Tenet Healthcare in the 4th quarter valued at about $49,001,000. Proficio Capital Partners LLC bought a new position in shares of Tenet Healthcare in the 4th quarter valued at about $5,832,000. Assetmark Inc. grew its holdings in shares of Tenet Healthcare by 173.1% in the 4th quarter. Assetmark Inc. now owns 14,871 shares of the company’s stock valued at $1,877,000 after acquiring an additional 9,425 shares in the last quarter. Victory Capital Management Inc. grew its holdings in shares of Tenet Healthcare by 68.9% in the 4th quarter. Victory Capital Management Inc. now owns 507,055 shares of the company’s stock valued at $64,006,000 after acquiring an additional 206,907 shares in the last quarter. Finally, LGT Fund Management Co Ltd. bought a new position in shares of Tenet Healthcare in the 4th quarter valued at about $2,073,000. Institutional investors own 95.44% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on THC shares. JPMorgan Chase & Co. reiterated an “overweight” rating and set a $175.00 price target on shares of Tenet Healthcare in a report on Tuesday, December 17th. StockNews.com downgraded shares of Tenet Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday. Wells Fargo & Company downgraded shares of Tenet Healthcare from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $205.00 to $150.00 in a research report on Monday, November 25th. Barclays lowered their price objective on shares of Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating for the company in a research report on Thursday, February 13th. Finally, Raymond James cut shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price objective on the stock. in a research note on Friday, November 22nd. Four analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $163.88.

Tenet Healthcare Price Performance

THC stock opened at $125.44 on Friday. The firm has a market cap of $11.93 billion, a price-to-earnings ratio of 3.89, a PEG ratio of 1.02 and a beta of 2.06. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. Tenet Healthcare Co. has a 12-month low of $90.03 and a 12-month high of $171.20. The company’s fifty day simple moving average is $132.72 and its 200 day simple moving average is $146.39.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. On average, analysts expect that Tenet Healthcare Co. will post 12.24 earnings per share for the current year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.